Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
Dimethylglycine (2 trials)
procalcitonin (1 trial)
selenium (4 trials)
Heart Diseases (Phase 3)
HIV Infections (Phase 3)
Sepsis (Phase 3)
Shock (Phase 2)
Shock, Septic (Phase 3)
Toxemia (Phase 3)
Ventricular Dysfunction (Phase 3)
Ventricular Dysfunction, Left (Phase 3)
Trials (6 total)
Trial APIs (3 total)